New drug approved by FDA for treating growth hormone deficiency

The new drug, somapacitan, has been approved by the US Food and Drug Administration as a replacement growth hormone in adults with growth hormone deficiency and is the first drug that can be administered weekly, rather than daily.

Medscape

Subscribe to our email alerts